dimethylmyleran has been researched along with Graft-Versus-Host Disease in 1 studies
dimethylmyleran: RN given refers to cpd without isomeric designation
dimethylmyleran : A methanesulfonate ester that is hexane-2,5-diol in which the hydrogens of the hydroxy groups are replaced by methanesulfonyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Bekkum, DW | 1 |
1 review available for dimethylmyleran and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Conditioning regimens for marrow grafting.
Topics: Animals; Antilymphocyte Serum; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporins | 1984 |